We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

180 hedge funds and large institutions have $2.29B invested in Pacira BioSciences in 2016 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 77 increasing their positions, 60 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 60

16% less funds holding

Funds holding: 214 → 180 (-34)

16% less call options, than puts

Call options by funds: $22.9M | Put options by funds: $27.3M

30% less capital invested

Capital invested by funds: $3.29B → $2.29B (-$999M)

45% less funds holding in top 10

Funds holding in top 10: 11 → 6 (-5)

57% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 56

Holders
180
Holders Change
-34
Holders Change %
-15.89%
% of All Funds
4.8%
Holding in Top 10
6
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-45.45%
% of All Funds
0.16%
New
24
Increased
77
Reduced
60
Closed
56
Calls
$22.9M
Puts
$27.3M
Net Calls
-$4.42M
Net Calls Change
+$14.1M

Top Buyers

1
MC
Maverick Capital
Texas
+$94.2M
2
FAM
Fred Alger Management
New York
+$63.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$43.8M
4
NCGI
Next Century Growth Investors
Minnesota
+$15.9M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$15.9M

Top Sellers

1
JHIU
Janus Henderson Investors US
Colorado
-$51.5M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$43.8M
3
MCM
Marsico Capital Management
Colorado
-$31.4M
4
DM
Deerfield Management
New York
-$28.5M
5
MTIP
Magee Thomson Investment Partners
California
-$13.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
51
Macquarie Group
Australia
$4.21M +$4.64M +79,390 New
CPS
52
Counsel Portfolio Services
Ontario, Canada
$4.15M +$1.42M +24,336 +45%
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$4.1M +$583K +9,959 +15%
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$3.86M -$263K -4,500 -6%
HCMT
55
Highland Capital Management (Texas)
Texas
$3.85M +$4.25M +72,698 New
TD Asset Management
56
TD Asset Management
Ontario, Canada
$3.81M -$158K -2,700 -4%
RHJA
57
Rice Hall James & Associates
California
$3.79M +$97.9K +1,674 +2%
Barclays
58
Barclays
United Kingdom
$3.67M +$2.16M +36,956 +110%
American Century Companies
59
American Century Companies
Missouri
$3.51M -$14.8K -253 -0.4%
GC
60
Guggenheim Capital
Illinois
$3.45M +$1.31M +22,368 +52%
Two Sigma Investments
61
Two Sigma Investments
New York
$3.39M +$3.09M +52,853 +474%
AllianceBernstein
62
AllianceBernstein
Tennessee
$3.28M +$994 +17 +0%
Morgan Stanley
63
Morgan Stanley
New York
$3.18M -$3.54M -60,588 -50%
Swiss National Bank
64
Swiss National Bank
Switzerland
$3.13M +$819K +14,000 +30%
RFC
65
Russell Frank Company
Washington
$3.12M -$1.39M -23,755 -29%
AIC
66
AWM Investment Company
New York
$2.95M +$519K +8,881 +19%
TA
67
Teachers Advisors
New York
$2.88M -$6.42M -109,703 -67%
Royal Bank of Canada
68
Royal Bank of Canada
Ontario, Canada
$2.54M +$2.68M +45,898 +2,255%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$2.31M +$71.1K +1,215 +3%
New York State Common Retirement Fund
70
New York State Common Retirement Fund
New York
$2.27M -$860K -14,698 -26%
AA
71
ALPS Advisors
Colorado
$2.21M -$395K -6,752 -14%
PI
72
Putnam Investments
Massachusetts
$2.2M -$1.91M -32,585 -44%
RPAM
73
Rhenman & Partners Asset Management
Sweden
$2.12M +$292K +5,000 +14%
Citigroup
74
Citigroup
New York
$1.99M +$1.02M +17,428 +87%
NIP
75
Nicholas Investment Partners
California
$1.87M -$908K -15,525 -31%
1 2
3
4 5

PCRX Hedge Fund Activity: Q1 2016 in Review

180 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q1 2016, worth a combined $2.29B — down 30% from $3.29B a quarter earlier.

Sellers outnumbered buyers: 56 funds closed out of PCRX and 24 opened new positions — a net loss of 32 holders — while 60 trimmed existing stakes and 77 added.

The largest buyer was Maverick Capital, opening a new position worth an estimated $94.2M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $51.5M sold.

  • 180 institutional investors held Pacira BioSciences (PCRX) as of Q1 2016, down from 214 in Q4 2015.
  • Funds reported $2.29B of Pacira BioSciences stock for Q1 2016, down 30% quarter-over-quarter.
  • 24 funds opened new Pacira BioSciences positions in Q1 2016 and 56 closed out, a net change of -32 holders.
  • The largest Pacira BioSciences buyer in Q1 2016 was Maverick Capital, an estimated $94.2M added.
  • The largest Pacira BioSciences seller in Q1 2016 was Janus Henderson Investors US, an estimated $51.5M sold.

Based on aggregated 13F filings for Q1 2016.